| Year |
Citation |
Score |
| 2021 |
Gieszer B, Megyesfalvi Z, Dulai V, Papay J, Kovalszky I, Timar J, Fillinger J, Harko T, Pipek O, Teglasi V, Regos E, Papp G, Szallasi Z, Laszlo V, Renyi-Vamos F, et al. EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study. Translational Lung Cancer Research. 10: 662-674. PMID 33718012 DOI: 10.21037/tlcr-20-814 |
0.687 |
|
| 2020 |
Nagy N, Reis H, Hadaschik B, Niedworok C, Módos O, Szendrői A, Bíró K, Hager T, Herold T, Ablat J, Black PC, Okon K, Tolkach Y, Csizmarik A, Oláh C, et al. Prevalence of APC and PTEN Alterations in Urachal Cancer. Pathology Oncology Research : Por. PMID 32754865 DOI: 10.1007/S12253-020-00872-6 |
0.363 |
|
| 2020 |
Timar J, Kashofer K. Molecular epidemiology and diagnostics of KRAS mutations in human cancer. Cancer Metastasis Reviews. PMID 32725342 DOI: 10.1007/S10555-020-09915-5 |
0.377 |
|
| 2020 |
Uhlyarik A, Piurko V, Papai Z, Raso E, Lahm E, Kiss E, Sikter M, Vachaja J, Kenessey I, Timar J. EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy. Cancers. 12. PMID 32155907 DOI: 10.3390/Cancers12030614 |
0.414 |
|
| 2020 |
Baranyi M, Rittler D, Molnár E, Shirasawa S, Jalsovszky I, Varga IK, Hegedűs L, Németh A, Dank M, Aigner C, Tóvári J, Tímár J, Hegedűs B, Garay T. Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In Vivo. Pathology Oncology Research : Por. PMID 31902117 DOI: 10.1007/S12253-019-00789-9 |
0.423 |
|
| 2019 |
Rittler D, Baranyi M, Molnár E, Garay T, Jalsovszky I, Varga IK, Hegedűs L, Aigner C, Tóvári J, Tímár J, Hegedűs B. The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb. International Journal of Molecular Sciences. 20. PMID 31623406 DOI: 10.3390/Ijms20194917 |
0.375 |
|
| 2019 |
Ghimessy AK, Gellert A, Schlegl E, Hegedus B, Raso E, Barbai T, Timar J, Ostoros G, Megyesfalvi Z, Gieszer B, Moldvay J, Renyi-Vamos F, Lohinai Z, Hoda MA, Klikovits T, et al. KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy. Cancers. 11. PMID 31600989 DOI: 10.3390/Cancers11101514 |
0.342 |
|
| 2019 |
Molnár E, Garay T, Donia M, Baranyi M, Rittler D, Berger W, Tímár J, Grusch M, Hegedűs B. Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression. International Journal of Molecular Sciences. 20. PMID 31514305 DOI: 10.3390/Ijms20184484 |
0.393 |
|
| 2019 |
Ladányi A, Tímár J. Immunologic and immunogenomic aspects of tumor progression. Seminars in Cancer Biology. PMID 31419526 DOI: 10.1016/J.Semcancer.2019.08.011 |
0.379 |
|
| 2019 |
Doma V, Kárpáti S, Rásó E, Barbai T, Tímár J. Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma. Bmc Cancer. 19: 786. PMID 31391014 DOI: 10.1186/S12885-019-5990-9 |
0.344 |
|
| 2019 |
Téglási V, Pipek O, Lózsa R, Berta K, Szüts D, Harkó T, Vadász P, Rojkó L, Döme B, Bagó AG, Tímár J, Moldvay J, Szállási Z, Reiniger L. PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis. Clinical Lung Cancer. PMID 31178388 DOI: 10.1016/J.Cllc.2019.05.008 |
0.355 |
|
| 2019 |
Reiniger L, Téglási V, Pipek O, Rojkó L, Glasz T, Vágvölgyi A, Kovalszky I, Gyulai M, Lohinai Z, Rásó E, Tímár J, Döme B, Szállási Z, Moldvay J. Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma. Acta Oncologica (Stockholm, Sweden). 1-8. PMID 31002007 DOI: 10.1080/0284186X.2019.1598575 |
0.316 |
|
| 2019 |
Gil J, Betancourt LH, Pla I, Sanchez A, Appelqvist R, Miliotis T, Kuras M, Oskolas H, Kim Y, Horvath Z, Eriksson J, Berge E, Burestedt E, Jönsson G, Baldetorp B, ... ... Timar J, et al. Clinical protein science in translational medicine targeting malignant melanoma. Cell Biology and Toxicology. PMID 30900145 DOI: 10.1007/S10565-019-09468-6 |
0.385 |
|
| 2019 |
Burián Z, Ladányi A, Barbai T, Piurkó V, Garay T, Rásó E, Tímár J. Selective Inhibition of HIF1α Expression by ZnSO Has Antitumoral Effects in Human Melanoma. Pathology Oncology Research : Por. PMID 30613921 DOI: 10.1007/S12253-018-00573-1 |
0.412 |
|
| 2019 |
Uhlyarik A, Piurko V, Vizkeleti L, Pápai Z, Rásó E, Lahm E, Kiss E, Sikter M, Vachaja J, Kenessey I, Tímár J. EGFR Protein Expression of KRAS Wild-Type Colorectal Cancer: Predictive Value of the Sidedness for Efficacy of Anti-EGFR Therapy. Pathology Oncology Research : Por. PMID 30612313 DOI: 10.1007/S12253-018-00572-2 |
0.383 |
|
| 2018 |
Imrédi E, Liszkay G, Kenessey I, Plotár V, Gödény M, Tóth B, Fedorcsák I, Tímár J. Aquaporin-1 Protein Expression of the Primary Tumor May Predict Cerebral Progression of Cutaneous Melanoma. Pathology Oncology Research : Por. PMID 30378011 DOI: 10.1007/S12253-018-0513-6 |
0.417 |
|
| 2018 |
Varga K, Hollósi A, Pászty K, Hegedűs L, Szakács G, Tímár J, Papp B, Enyedi Á, Padányi R. Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells. Bmc Cancer. 18: 1029. PMID 30352569 DOI: 10.1186/S12885-018-4945-X |
0.323 |
|
| 2018 |
Kenessey I, Kramer Z, István L, Cserepes MT, Garay T, Hegedűs B, Dobos J, Tímár J, Tóvári J. Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model. Melanoma Research. PMID 30124539 DOI: 10.1097/Cmr.0000000000000488 |
0.365 |
|
| 2018 |
Diossy M, Reiniger L, Sztupinszki Z, Krzystanek M, Timms KM, Neff C, Solimeno C, Pruss D, Eklund AC, Tóth E, Kiss O, Rusz O, Cserni G, Zombori T, Székely B, et al. Breast cancer brain metastases show increased levels of genomic aberration based homologous recombination deficiency scores relative to their corresponding primary tumors. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29917049 DOI: 10.1093/Annonc/Mdy216 |
0.408 |
|
| 2018 |
Tímár J, Hegedüs B, Rásó E. The role of lipid signaling in the progression of malignant melanoma. Cancer Metastasis Reviews. PMID 29808460 DOI: 10.1007/S10555-018-9729-X |
0.339 |
|
| 2018 |
Molnár E, Rittler D, Baranyi M, Grusch M, Berger W, Döme B, Tóvári J, Aigner C, Tímár J, Garay T, Hegedűs B. Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells. Bmc Cancer. 18: 542. PMID 29739364 DOI: 10.1186/S12885-018-4455-X |
0.404 |
|
| 2018 |
Rojkó L, Reiniger L, Téglási V, Fábián K, Pipek O, Vágvölgyi A, Agócs L, Fillinger J, Kajdácsi Z, Tímár J, Döme B, Szállási Z, Moldvay J. Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients. Journal of Cancer Research and Clinical Oncology. PMID 29675791 DOI: 10.1007/S00432-018-2642-4 |
0.342 |
|
| 2018 |
Reis H, van der Vos KE, Niedworok C, Herold T, Módos O, Szendrői A, Hager T, Ingenwerth M, Vis DJ, Behrendt MA, de Jong J, van der Heijden MS, Peyronnet B, Mathieu R, Wiesweg M, ... ... Timar J, et al. Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas. International Journal of Cancer. PMID 29672836 DOI: 10.1002/Ijc.31547 |
0.339 |
|
| 2018 |
Ryska A, Berzinec P, Brcic L, Cufer T, Dziadziuszko R, Gottfried M, Kovalszky I, Olszewski W, Oz B, Plank L, Timar J. NSCLC molecular testing in Central and Eastern European countries. Bmc Cancer. 18: 269. PMID 29523116 DOI: 10.1186/S12885-018-4023-4 |
0.324 |
|
| 2018 |
Timar J, Piurko V, Kenessey I, Raso E, Lahm E, Kiss E, Sikter M, Vachaja J, Papai Z, Uhlyarik A. EGFR protein expression of the metastatic colorectal cancer as a prognostic/predictive factor for anti-EGFR antibody therapy. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E15548 |
0.321 |
|
| 2018 |
Moldvay J, Rojkó L, Téglási V, Fábián K, Pipek O, Vágvölgyi A, Agócs L, Fillinger J, Kajdácsi Z, Tímár J, Döme B, Szállási Z, Reiniger L. P2.04-08 Platinum-Based Chemotherapy is Associated with Altered PD-L1 Expression in Lung Cancer Journal of Thoracic Oncology. 13. DOI: 10.1016/J.Jtho.2018.08.1232 |
0.321 |
|
| 2017 |
Birtalan E, Danos K, Gurbi B, Brauswetter D, Halasz J, Kalocsane Piurko V, Acs B, Antal B, Mihalyi R, Pato A, Fent Z, Polony G, Timar J, Tamas L. Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer. Applied Immunohistochemistry & Molecular Morphology : Aimm. PMID 29271789 DOI: 10.1097/Pai.0000000000000590 |
0.374 |
|
| 2017 |
Kafatos G, Niepel D, Lowe K, Jenkins-Anderson S, Westhead H, Garawin T, Traugottová Z, Bilalis A, Molnar E, Timar J, Toth E, Gouvas N, Papaxoinis G, Murray S, Mokhtar N, et al. RAS mutation prevalence among patients with metastatic colorectal cancer: a meta-analysis of real-world data. Biomarkers in Medicine. PMID 28747067 DOI: 10.2217/Bmm-2016-0358 |
0.329 |
|
| 2017 |
Hegedüs L, Padányi R, Molnár J, Pászty K, Varga K, Kenessey I, Sárközy E, Wolf M, Grusch M, Hegyi Z, Homolya L, Aigner C, Garay T, Hegedüs B, Tímár J, et al. Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca(2+) Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK. Frontiers in Oncology. 7: 95. PMID 28596940 DOI: 10.3389/Fonc.2017.00095 |
0.382 |
|
| 2017 |
Lohinai Z, Klikovits T, Moldvay J, Ostoros G, Raso E, Timar J, Fabian K, Kovalszky I, Kenessey I, Aigner C, Renyi-Vamos F, Klepetko W, Dome B, Hegedus B. KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis. Scientific Reports. 7: 39721. PMID 28051122 DOI: 10.1038/Srep39721 |
0.313 |
|
| 2017 |
Modos O, Keresztes D, Nyirády P, Szendröi A, Tímár J, Szász A, Reis H, Niedworok C, Hadaschik B, Hollósi P, Baghy K, Kovalszky I, Okon K, Golabek T, Chlosta P, et al. Molecular and therapeutic aspects of advanced urachal cancer European Urology Supplements. 16: e2840. DOI: 10.1016/S1569-9056(17)31982-6 |
0.34 |
|
| 2017 |
Klikovits T, Lohinai Z, Fabian K, Gyulai M, Fodor A, Varga J, Baranya E, Pipek O, Csabai I, Szallasi Z, Tímár J, Hegedus B, Dome B, Moldvay J. P1.06-012 Central and Peripheral Lung Adenocarcinomas Exhibit Different Timing and Predilection for Distant Metastasis: Topic: Advanced General Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2016.11.876 |
0.315 |
|
| 2017 |
Fabian K, Gyulai M, Furák J, Várallyay P, Jäckel M, Bogos K, Dome B, Pápay J, Tímár J, Szallasi Z, Moldvay J. P2.03b-005 Correlation between Primary Tumor Location and Brain Metastasis Development or Peritumoral Brain Edema in Lung Cancer: Topic: Brain Meta Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2016.11.1286 |
0.718 |
|
| 2016 |
Brauswetter D, Birtalan E, Danos K, Kocsis A, Krenacs T, Timar J, Mihalyi R, Horcsik D, Polony G, Tamas L, Petak I. p16(INK4) expression is of prognostic and predictive value in oropharyngeal cancers independent of human papillomavirus status: a Hungarian study. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (Eufos) : Affiliated With the German Society For Oto-Rhino-Laryngology - Head and Neck Surgery. PMID 27999998 DOI: 10.1007/S00405-016-4412-8 |
0.323 |
|
| 2016 |
Szekely B, Nagy ZI, Farago Z, Kiss O, Lotz G, Kovacs KA, Madaras L, Udvarhelyi N, Dank M, Szentmartoni G, Baranyai Z, Harsanyi L, Tőkés AM, Timar J, Szasz AM, et al. Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastases: an autopsy study of 25 patients. Clinical & Experimental Metastasis. PMID 27885435 DOI: 10.1007/S10585-016-9830-X |
0.374 |
|
| 2016 |
Kenessey I, Kói K, Horváth O, Cserepes M, Molnár D, Izsák V, Dobos J, HegedÅ S B, Tóvári J, Tímár J. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models. Oncotarget. PMID 27780929 DOI: 10.18632/Oncotarget.12806 |
0.39 |
|
| 2016 |
Fábián K, Gyulai M, Furák J, Várallyay P, Jäckel M, Bogos K, Döme B, Pápay J, Tímár J, Szállási Z, Moldvay J. Significance of Primary Tumor Location and Histology for Brain Metastasis Development and Peritumoral Brain Edema in Lung Cancer. Oncology. PMID 27562339 DOI: 10.1159/000447517 |
0.722 |
|
| 2016 |
Módos O, Reis H, Niedworok C, Rübben H, Szendröi A, Szász MA, Tímár J, Baghy K, Kovalszky I, Golabek T, Chlosta P, Okon K, Peyronnet B, Mathieu R, Shariat SF, et al. Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma - occurence and prognostic significance. Oncotarget. PMID 27283768 DOI: 10.18632/Oncotarget.9828 |
0.363 |
|
| 2016 |
Szendrői A, Szász AM, Kardos M, Tőkés AM, Idan R, Szűcs M, Kulka J, Nyirády P, Szendrői M, Szállási Z, Győrffy B, Tímár J. Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer. Oncotarget. PMID 27244898 DOI: 10.18632/Oncotarget.9669 |
0.388 |
|
| 2016 |
Tímár J, Vizkeleti L, Doma V, Barbai T, Rásó E. Genetic progression of malignant melanoma Cancer and Metastasis Reviews. 35: 93-107. PMID 26970965 DOI: 10.1007/S10555-016-9613-5 |
0.377 |
|
| 2016 |
Tímár J. Genetic evolution during tumor progression: from basic research to clinical practice. Cancer Metastasis Reviews. 35: 3-4. PMID 26961284 DOI: 10.1007/S10555-016-9603-7 |
0.305 |
|
| 2016 |
Imrédi E, Tóth B, Doma V, Barbai T, Rásó E, Kenessey I, Tímár J. Aquaporin 1 protein expression is associated with BRAF V600 mutation and adverse prognosis in cutaneous melanoma. Melanoma Research. 26: 254-60. PMID 26848795 DOI: 10.1097/Cmr.0000000000000243 |
0.357 |
|
| 2016 |
Garay TM, Molnar E, Rittler D, Berger W, Döme B, Timar J, Hegedus B. Abstract 3831: Oncogenic BRAF and concomitant RAS or PTEN/PI3K mutations determine together the response to RAS/RAF/PI3K signaling network inhibition Cancer Research. 76: 3831-3831. DOI: 10.1158/1538-7445.Am2016-3831 |
0.31 |
|
| 2015 |
Madaras L, Balint N, Gyorffy B, Tokes AM, Barshack I, Yosepovich A, Friedman E, Paluch-Shimon S, Zippel D, Baghy K, Timar J, Kovalszky I, Kulka J, Szasz AM. BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters? Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 83: 1-12. PMID 26566278 DOI: 10.1159/000439135 |
0.327 |
|
| 2015 |
Barbai T, Fejős Z, Puskas LG, Tímár J, Rásó E. The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma. Oncotarget. 6: 29111-28. PMID 26320180 DOI: 10.18632/Oncotarget.5059 |
0.444 |
|
| 2015 |
Garay T, Molnár E, Juhász É, László V, Barbai T, Dobos J, Schelch K, Pirker C, Grusch M, Berger W, Tímár J, Heged?s B. Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations. Pathology Oncology Research : Por. PMID 25749811 DOI: 10.1007/S12253-015-9916-9 |
0.335 |
|
| 2015 |
Szasz AM, Szirtes I, Tihanyi B, Barkaszi B, Baranyai Z, Tihanyi T, Harsanyi L, Timar J, Kulka J. Basaloid carcinoma of the pancreas--clinicopathological presentation and oncogenetic snapshot of a rare entity. Virchows Archiv : An International Journal of Pathology. 466: 237-41. PMID 25432630 DOI: 10.1007/S00428-014-1662-Y |
0.404 |
|
| 2015 |
Szabo V, Bugyik E, Dezso K, Ecker N, Nagy P, Timar J, Tovari J, Laszlo V, Bridgeman VL, Wan E, Frentzas S, Vermeulen PB, Reynolds AR, Dome B, Paku S. Mechanism of tumour vascularization in experimental lung metastases. The Journal of Pathology. 235: 384-96. PMID 25319725 DOI: 10.1002/Path.4464 |
0.337 |
|
| 2015 |
Podmaniczky E, Fábián K, Pápay J, Puskás R, Gyulai M, Furák J, Tiszlavicz L, Losonczy G, Tímár J, Moldvay J. Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer. Pathology Oncology Research : Por. 21: 423-31. PMID 25194563 DOI: 10.1007/S12253-014-9839-X |
0.764 |
|
| 2015 |
Kenessey I, Kói K, Cserepes M, Dobos J, Hegedűs B, Tóvári J, Tímár J. Abstract 47: KRAS-mutation dependent effect of zoledronic acid in human NSCLC preclinical models Cancer Research. 75: 47-47. DOI: 10.1158/1538-7445.Am2015-47 |
0.438 |
|
| 2015 |
Borka K, Winternitz T, Tihanyi B, Zalatnai A, Lakatos P, Patócs A, Harsányi L, Tímár J. Coexistence of a pancreatic serous cystadenoma and a VIP-producing neuroendocrine tumor Pancreatology. 15: S110-S111. DOI: 10.1016/J.Pan.2015.05.393 |
0.357 |
|
| 2014 |
Popper HH, Tímár J, Ryska A, Olszewski W. Minimal requirements for the molecular testing of lung cancer. Translational Lung Cancer Research. 3: 301-4. PMID 25806315 DOI: 10.3978/J.Issn.2218-6751.2014.10.02 |
0.408 |
|
| 2014 |
Popper HH, Ryska A, Tímár J, Olszewski W. Molecular testing in lung cancer in the era of precision medicine. Translational Lung Cancer Research. 3: 291-300. PMID 25806314 DOI: 10.3978/J.Issn.2218-6751.2014.10.01 |
0.401 |
|
| 2014 |
Ladányi A, Sebestyén T, Mohos A, Liszkay G, Somlai B, Tóth E, Tímár J. Ectopic lymphoid structures in primary cutaneous melanoma. Pathology Oncology Research : Por. 20: 981-5. PMID 24781762 DOI: 10.1007/S12253-014-9784-8 |
0.401 |
|
| 2014 |
Cserepes M, Ostoros G, Lohinai Z, Raso E, Barbai T, Timar J, Rozsas A, Moldvay J, Kovalszky I, Fabian K, Gyulai M, Ghanim B, Laszlo V, Klikovits T, Hoda MA, et al. Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy. European Journal of Cancer (Oxford, England : 1990). 50: 1819-28. PMID 24768329 DOI: 10.1016/J.Ejca.2014.04.001 |
0.323 |
|
| 2014 |
Virág J, Kenessey I, Haberler C, Piurkó V, Bálint K, Döme B, Tímár J, Garami M, Hegedűs B. Angiogenesis and angiogenic tyrosine kinase receptor expression in pediatric brain tumors. Pathology Oncology Research : Por. 20: 417-26. PMID 24190638 DOI: 10.1007/S12253-013-9711-4 |
0.456 |
|
| 2014 |
Garay T, Molnár E, László V, Hoda MA, Tímár J, Klepetko W, Berger W, Döme B, Hegedus B. P33. Potential clinical relevance of in vitro migratory activity in malignant pleural mesothelioma. Translational Lung Cancer Research. 3. DOI: 10.3978/J.Issn.2218-6751.2014.Ab045 |
0.337 |
|
| 2014 |
Garay T, Kenessey I, Laszlo V, Tovari J, Berger W, Kovacs L, Timar J, Hegedus B. Abstract B37: Prenylation inhibition induces cell death in NRAS mutant melanoma cells Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-B37 |
0.381 |
|
| 2014 |
Marjai T, Tihanyi B, Nehez L, Borka K, Szasz M, Timar J, Harsanyi L, Tihanyi T. Rare tumor of the pancreas - report of a case and review of the literature Pancreatology. 14: S42-S43. DOI: 10.1016/J.Pan.2014.05.524 |
0.304 |
|
| 2014 |
Tihanyi B, Borka K, Nehez L, Marjai T, Barkaszi B, Timar J, Harsanyi L, Tihanyi T. Characteristic of the intraductal papillary mucinous tumours (IPMTs) of the pancreas and correlation between the presence of chronic pancreatitis and the malignant potential Pancreatology. 14: S28-S29. DOI: 10.1016/J.Pan.2014.05.472 |
0.35 |
|
| 2013 |
Moldvay J, Barbai T, Bogos K, Piurko V, Fillinger J, Popper HH, Tímár J. EGFR autophosphorylation but not protein score correlates with histologic and molecular subtypes in lung adenocarcinoma. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 22: 204-9. PMID 24193009 DOI: 10.1097/Pdm.0B013E3182936957 |
0.39 |
|
| 2013 |
Szász AM, Ács B, Ágoston E, Sztupinszki Z, Tőkés AM, Szittya L, Székely B, Szendrői M, Li Q, Harsányi L, Tímár J, Szállási Z, Swanton C, Győrffy B, Kulka J. [Simplified, low-cost gene expression profiling for the prediction of outcome in breast cancer based on routine histologic specimens]. Orvosi Hetilap. 154: 627-32. PMID 23587542 DOI: 10.1556/Oh.2013.29590 |
0.314 |
|
| 2013 |
Lövey J, Nie D, Tóvári J, Kenessey I, Tímár J, Kandouz M, Honn KV. Radiosensitivity of human prostate cancer cells can be modulated by inhibition of 12-lipoxygenase. Cancer Letters. 335: 495-501. PMID 23523613 DOI: 10.1016/J.Canlet.2013.03.012 |
0.404 |
|
| 2013 |
Raso-Barnett L, Banky B, Barbai T, Becsagh P, Timar J, Raso E. Demonstration of a melanoma-specific CD44 alternative splicing pattern that remains qualitatively stable, but shows quantitative changes during tumour progression. Plos One. 8: e53883. PMID 23342032 DOI: 10.1371/Journal.Pone.0053883 |
0.342 |
|
| 2013 |
Dobos J, Mohos A, Tóvári J, Rásó E, Lőrincz T, Zádori G, Tímár J, Ladányi A. Sex-dependent liver colonization of human melanoma in SCID mice--role of host defense mechanisms. Clinical & Experimental Metastasis. 30: 497-506. PMID 23203681 DOI: 10.1007/S10585-012-9554-5 |
0.373 |
|
| 2013 |
Timar J, Szasz AM, Kardos M, Tokes A, Kulka J, Szendroi M, Szendroi A. Expression of HIF1a and HIF2a in bone metastatic clear cell renal cell cancer and use as prognostic markers. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E15523 |
0.357 |
|
| 2013 |
Borka K, Kenessey I, Hujber-Pichler R, Szűcs N, Rácz K, Bodoky G, Harsányi L, Tímár J. Prognostic Factors in Neuroendocrine Tumors of the Pancreas Pancreatology. 13: S82. DOI: 10.1016/J.Pan.2013.04.287 |
0.365 |
|
| 2013 |
Tihanyi B, Borka K, Nehéz L, Barkaszi B, Tímár J, Harsányi L, Tihanyi T. Collected series of resected intraductal papillary mucinous tumours (IPMTs) of the pancreas and correlation between the mucin expression profile and the malignant potential Pancreatology. 13: S79. DOI: 10.1016/J.Pan.2013.04.277 |
0.398 |
|
| 2013 |
Fehniger TE, Végvári Á, Rezeli M, Döme B, Tímár J, Marko-Varga G. International biobanking for lung cancer and COPD as the future resource for clinical protein research Eupa Open Proteomics. 1: 3-7. DOI: 10.1016/J.Euprot.2013.04.001 |
0.313 |
|
| 2012 |
Bánky B, Rásó-Barnett L, Barbai T, Tímár J, Becságh P, Rásó E. Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression. Molecular Cancer. 11: 83. PMID 23151220 DOI: 10.1186/1476-4598-11-83 |
0.309 |
|
| 2012 |
Krenacs T, Kiszner G, Stelkovics E, Balla P, Teleki I, Nemeth I, Varga E, Korom I, Barbai T, Plotar V, Timar J, Raso E. Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis. Histochemistry and Cell Biology. 138: 653-67. PMID 22688676 DOI: 10.1007/S00418-012-0981-9 |
0.412 |
|
| 2012 |
Kenessey I, Bánki B, Márk A, Varga N, Tóvári J, Ladányi A, Rásó E, Tímár J. Revisiting CB1 receptor as drug target in human melanoma. Pathology Oncology Research : Por. 18: 857-66. PMID 22447182 DOI: 10.1007/S12253-012-9515-Y |
0.368 |
|
| 2012 |
Gyorffy B, Benke Z, Lánczky A, Balázs B, Szállási Z, Timár J, Schäfer R. RecurrenceOnline: An online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data Breast Cancer Research and Treatment. 132: 1025-1034. PMID 21773767 DOI: 10.1007/S10549-011-1676-Y |
0.328 |
|
| 2012 |
Györffy B, Weltz B, Benke Z, Timar J, Sztupinszki Z, Schaefer R. Abstract P2-10-24: Independent validation of Recurrence Online using 1,638 breast cancer microarray samples Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-10-24 |
0.346 |
|
| 2011 |
Bugyik E, Dezso K, Reiniger L, László V, Tóvári J, Tímár J, Nagy P, Klepetko W, Döme B, Paku S. Lack of angiogenesis in experimental brain metastases. Journal of Neuropathology and Experimental Neurology. 70: 979-91. PMID 22002424 DOI: 10.1097/Nen.0B013E318233Afd7 |
0.431 |
|
| 2011 |
Székely E, Törzsök P, Riesz P, Korompay A, Fintha A, Székely T, Lotz G, Nyirády P, Romics I, Tímár J, Schaff Z, Kiss A. Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 59: 932-41. PMID 21832144 DOI: 10.1369/0022155411418829 |
0.379 |
|
| 2011 |
Paku S, Dezso K, Bugyik E, Tóvári J, Tímár J, Nagy P, Laszlo V, Klepetko W, Döme B. A new mechanism for pillar formation during tumor-induced intussusceptive angiogenesis: inverse sprouting. The American Journal of Pathology. 179: 1573-85. PMID 21827961 DOI: 10.1016/J.Ajpath.2011.05.033 |
0.304 |
|
| 2011 |
Ladányi A, Kiss J, Mohos A, Somlai B, Liszkay G, Gilde K, Fejös Z, Gaudi I, Dobos J, Tímár J. Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunology, Immunotherapy : Cii. 60: 1729-38. PMID 21779876 DOI: 10.1007/S00262-011-1071-X |
0.713 |
|
| 2011 |
Szabó B, Nelhubel GA, Kárpáti A, Kenessey I, Jóri B, Székely C, Peták I, Lotz G, Hegedus Z, Hegedus B, Füle T, Döme B, Tímár J, Tóvári J. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. Oral Oncology. 47: 487-96. PMID 21498106 DOI: 10.1016/J.Oraloncology.2011.03.020 |
0.356 |
|
| 2011 |
Dobos J, Kenessey I, Tímár J, Ladányi A. Glucocorticoid receptor expression and antiproliferative effect of dexamethasone on human melanoma cells. Pathology Oncology Research : Por. 17: 729-34. PMID 21455635 DOI: 10.1007/S12253-011-9377-8 |
0.436 |
|
| 2011 |
Szendroi A, Szász MA, Szûcs M, Mavrogenis S, Riesz P, Szendroi M, Tímár J, Romics I. C168 Prognostic Relevance Of Hypoxia Regulated Genes In Renal Cell Cancer And Consecutive Distant Metastases European Urology Supplements. 10: 654. DOI: 10.1016/S1569-9056(11)61748-X |
0.34 |
|
| 2011 |
Ladanvi A, Kiss J, Mohos A, Somlai B, Liszkay G, Gilde K, Fejos Z, Gaudi I, Timár J. 9325 POSTER Prognostic Impact of B-Cell Infiltration in Melanoma European Journal of Cancer. 47. DOI: 10.1016/S0959-8049(11)72534-5 |
0.322 |
|
| 2011 |
Garav T, Juhasz E, Dobos J, Laszlo V, Berger W, Grusch M, Timar J, Hegedus B. 9307 POSTER Oncogenic Mutation Dependent Response to Growth Factors in Melanoma Cells European Journal of Cancer. 47: S654. DOI: 10.1016/S0959-8049(11)72516-3 |
0.303 |
|
| 2011 |
Törzsök P, Szekely E, Riesz P, Korompay A, Szekely T, Lotz G, Romics I, Timár J, Schaff Z, Kiss A. 7118 POSTER Expression of Claudins and Their Prognostic Significance in Non-invasive Urothelial Neoplasms of the Human Urinary Bladder European Journal of Cancer. 47: S510. DOI: 10.1016/S0959-8049(11)72033-0 |
0.332 |
|
| 2010 |
Strausz J, Tímár J. [Non-surgical biopsy in lung cancer: a paradigm shift]. Magyar Onkologia. 54: 297-301. PMID 21163760 DOI: 10.1556/Monkol.54.2010.4.19 |
0.398 |
|
| 2010 |
Tímár J, Hegedüs B, Rásó E. KRAS mutation testing of colorectal cancer for anti-EGFR therapy: dogmas versus evidence. Current Cancer Drug Targets. 10: 813-23. PMID 20718705 DOI: 10.2174/156800910793357989 |
0.343 |
|
| 2010 |
Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W, Jan Ankersmit H, Hegedus B, Renyi-Vamos F, Varga J, Lorincz Z, Paku S, Ostoros G, Rozsas A, Timar J, Dome B. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1120-9. PMID 20581707 DOI: 10.1097/Jto.0B013E3181E2C1Ff |
0.465 |
|
| 2010 |
Ostoros G, Döme B, Strausz J, Tímár J. [Changes in the diagnostic and therapeutic strategies of non-small cell lung cancer]. Magyar Onkologia. 54: 137-43. PMID 20576590 DOI: 10.1556/Monkol.54.2010.2.8 |
0.368 |
|
| 2010 |
Kenessey I, Keszthelyi M, Krámer Z, Berta J, Adám A, Dobos J, Mildner M, Flachner B, Cseh S, Barna G, Szokol B, Orfi L, Kéri G, Döme B, Klepetko W, et al. Inhibition of c-Met with the specific small molecule tyrosine kinase inhibitor SU11274 decreases growth and metastasis formation of experimental human melanoma. Current Cancer Drug Targets. 10: 332-42. PMID 20370683 DOI: 10.2174/156800910791190184 |
0.405 |
|
| 2010 |
Ladányi A, Mohos A, Somlai B, Liszkay G, Gilde K, Fejos Z, Gaudi I, Tímár J. FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma. Pathology Oncology Research : Por. 16: 303-9. PMID 20306313 DOI: 10.1007/S12253-010-9254-X |
0.454 |
|
| 2010 |
Keller-Pinter A, Bottka S, Timar J, Kulka J, Katona R, Dux L, Deak F, Szilak L. Syndecan-4 promotes cytokinesis in a phosphorylation-dependent manner. Cellular and Molecular Life Sciences : Cmls. 67: 1881-94. PMID 20229236 DOI: 10.1007/S00018-010-0298-6 |
0.31 |
|
| 2010 |
Tímár J, Gyorffy B, Rásó E. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little? Clinical & Experimental Metastasis. 27: 371-87. PMID 20177751 DOI: 10.1007/S10585-010-9307-2 |
0.436 |
|
| 2010 |
Virág J, Baksa G, Schaff Z, Tímár J, Garami M, Hegedũs B. Abstract 854: Claudin-5 expression in tumor cells is a potential prognostic marker in pediatric ependymoma Cancer Research. 70: 854-854. DOI: 10.1158/1538-7445.Am10-854 |
0.473 |
|
| 2009 |
Kopper L, Tímár J. [Validation study of KRAS mutation in colorectal cancer]. Magyar Onkologia. 53: 361-6. PMID 20071308 DOI: 10.1556/Monkol.53.2009.4.5 |
0.325 |
|
| 2009 |
Tímár J, Kásler M, Heringh A, Soós M, Mathiász D, Romány A, Józsa A, Szilák L, Forrai T, Patthy L, Kovács G. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium]. Magyar Onkologia. 53: 321-34. PMID 20071304 DOI: 10.1556/Monkol.53.2009.4.1 |
0.383 |
|
| 2009 |
Kenessey I, Simon E, Futosi K, Bereczky B, Kiss A, Erdödi F, Gallagher JT, Tímár J, Tóvári J. Antimigratory and antimetastatic effect of heparin-derived 4-18 unit oligosaccharides in a preclinical human melanoma metastasis model. Thrombosis and Haemostasis. 102: 1265-73. PMID 19967160 DOI: 10.1160/Th09-01-0059 |
0.77 |
|
| 2009 |
Pápay J, Sápi Z, Egri G, Gyulai M, Szende B, Losonczy G, Tímár J, Moldvay J. Platinum-based chemotherapy in lung cancer affects the expression of certain biomarkers including ERCC1. Pathology Oncology Research : Por. 15: 445-50. PMID 19253035 DOI: 10.1007/S12253-009-9155-Z |
0.753 |
|
| 2009 |
Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1741-6. PMID 19240177 DOI: 10.1158/1078-0432.Ccr-08-1372 |
0.44 |
|
| 2009 |
Dome B, Timar J, Ladanyi A, Paku S, Renyi-Vamos F, Klepetko W, Lang G, Dome P, Bogos K, Tovari J. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy. Critical Reviews in Oncology/Hematology. 69: 108-24. PMID 18768327 DOI: 10.1016/J.Critrevonc.2008.06.009 |
0.399 |
|
| 2009 |
Moldvay J, Sapi Z, Egri G, Gyulai M, Szende B, Losonczy G, Timar J, Papay J. 62P Platinum-Based Chemotherapy In Lung Cancer Affects The Expression Of Certain Biomarkers Including Ercc Lung Cancer. 64. DOI: 10.1016/S0169-5002(09)70185-0 |
0.754 |
|
| 2008 |
Tóvári J, Pirker R, Tímár J, Ostoros G, Kovács G, Döme B. Erythropoietin in cancer: an update. Current Molecular Medicine. 8: 481-91. PMID 18781955 DOI: 10.2174/156652408785747979 |
0.505 |
|
| 2008 |
Amir E, Hughes S, Blackhall F, Thatcher N, Ostoros G, Timar J, Tovari J, Kovacs G, Dome B. Targeting blood vessels for the treatment of non-small cell lung cancer. Current Cancer Drug Targets. 8: 392-403. PMID 18690845 DOI: 10.2174/156800908785133187 |
0.415 |
|
| 2008 |
Tímár J, Láng I. [The RAS paradox of the EGFR-targeted therapy in colorectal cancer]. Magyar Onkologia. 52: 185-91. PMID 18640895 DOI: 10.1556/Monkol.52.2008.2.7 |
0.307 |
|
| 2008 |
Tímár J, Döme B. Antiangiogenic drugs and tyrosine kinases. Anti-Cancer Agents in Medicinal Chemistry. 8: 462-9. PMID 18537529 DOI: 10.2174/187152008784533035 |
0.317 |
|
| 2008 |
Lövey J, Bereczky B, Gilly R, Kenessey I, Rásó E, Simon E, Dobos J, Vágó A, Kásler M, Döme B, Tímár J, Tóvári J. Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 184: 1-7. PMID 18188516 DOI: 10.1007/S00066-008-1745-2 |
0.794 |
|
| 2008 |
Dome B, Dobos J, Tovari J, Paku S, Kovacs G, Ostoros G, Timar J. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 73: 186-93. PMID 18000872 DOI: 10.1002/Cyto.A.20480 |
0.391 |
|
| 2007 |
Badalian G, Barbai T, Rásó E, Derecskei K, Szendrôi M, Tímár J. Phenotype of bone metastases of non-small cell lung cancer: epidermal growth factor receptor expression and K-RAS mutational status. Pathology Oncology Research : Por. 13: 99-104. PMID 17607370 DOI: 10.1007/Bf02893484 |
0.384 |
|
| 2007 |
Lövey J, Kenessey I, Rásó E, Dobos J, Vágó A, Kásler M, Futosi K, Döme B, Tímár J, Tóvári J. [Human recombinant erythropoietin-alpha increases the efficacy of irradiation in preclinical model]. Magyar Onkologia. 51: 53-61. PMID 17417676 |
0.312 |
|
| 2007 |
Kiss J, Tímár J, Somlai B, Gilde K, Fejôs Z, Gaudi I, Ladányi A. Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma. Pathology Oncology Research : Por. 13: 21-31. PMID 17387385 DOI: 10.1007/Bf02893437 |
0.724 |
|
| 2007 |
Deli T, Varga N, Adám A, Kenessey I, Rásó E, Puskás LG, Tóvári J, Fodor J, Fehér M, Szigeti GP, Csernoch L, Tímár J. Functional genomics of calcium channels in human melanoma cells. International Journal of Cancer. Journal International Du Cancer. 121: 55-65. PMID 17330843 DOI: 10.1002/Ijc.22621 |
0.304 |
|
| 2007 |
Ladányi A, Kiss J, Somlai B, Gilde K, Fejos Z, Mohos A, Gaudi I, Tímár J. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunology, Immunotherapy : Cii. 56: 1459-69. PMID 17279413 DOI: 10.1007/S00262-007-0286-3 |
0.672 |
|
| 2007 |
Döme B, Hendrix MJ, Paku S, Tóvári J, Tímár J. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. The American Journal of Pathology. 170: 1-15. PMID 17200177 DOI: 10.2353/Ajpath.2007.060302 |
0.329 |
|
| 2007 |
Lukits J, Remenár E, Rásó E, Ladányi A, Kásler M, Tímár J. Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer. International Journal of Oncology. 30: 155-60. PMID 17143524 DOI: 10.3892/Ijo.30.1.155 |
0.784 |
|
| 2006 |
Derecskei K, Moldvay J, Bogos K, Tímár J. Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx in paraffin-embedded cancer tissues. Pathology Oncology Research : Por. 12: 243-6. PMID 17189989 DOI: 10.1007/Bf02893421 |
0.368 |
|
| 2006 |
Lôrincz T, Tóth J, Badalian G, Tímár J, Szendrôi M. HER-2/neu genotype of breast cancer may change in bone metastasis. Pathology Oncology Research : Por. 12: 149-52. PMID 16998594 DOI: 10.1007/Bf02893361 |
0.404 |
|
| 2006 |
Kopper L, Tímár J. Genomics of renal cell cancer-- does it provide breakthrough? Pathology Oncology Research : Por. 12: 5-11. PMID 16554910 DOI: 10.1007/Bf02893425 |
0.364 |
|
| 2006 |
Lövey J, Lukits J, Remenár E, Koronczay K, Kásler M, Németh G, Tímár J. Antiangiogenic effects of radiotherapy but not initial microvessel density predict survival in inoperable oropharyngeal squamous cell carcinoma. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 182: 149-56. PMID 16520909 DOI: 10.1007/S00066-006-1447-6 |
0.78 |
|
| 2006 |
Döme B, Rásó E, Dobos J, Mészáros L, Varga N, Puskás LG, Fehér LZ, Lörincz T, Ladányi A, Trikha M, Honn KV, Tímár J. Erratum: Parallel expression of IIb3 and v3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype (International Journal of Cancer (2005) 116 (27-35)) International Journal of Cancer. 119. DOI: 10.1002/Ijc.21830 |
0.394 |
|
| 2005 |
Lövey J, Lukits J, Remenár E, Koronczay K, Kásler M, Németh G, Tímár J. [Radiation-induced alterations in microvessel density as predictor of treatment efficiency in oropharyngeal cancer]. Magyar Onkologia. 49: 307-13. PMID 16518474 |
0.787 |
|
| 2005 |
Rásó E, Tóvári J, Ladányi A, Varga N, Tímár J. Ligand-mimetic anti-alphaIIb beta3 antibody PAC-1 inhibits tyrosine signaling, proliferation and lung colonization of melanoma cells. Pathology Oncology Research : Por. 11: 218-23. PMID 16388318 DOI: 10.1007/Bf02893854 |
0.326 |
|
| 2005 |
Kopper L, Tímár J. Genomics of prostate cancer: is there anything to "translate"? Pathology Oncology Research : Por. 11: 197-203. PMID 16388315 DOI: 10.1007/Bf02893851 |
0.342 |
|
| 2005 |
Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey I, Ostoros G, Agocs L, Soltesz I, Dome B. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7344-53. PMID 16243806 DOI: 10.1158/1078-0432.Ccr-05-1077 |
0.301 |
|
| 2005 |
Harisi R, Dudás J, Timár F, Pogány G, Timár J, Kovalszky I, Szendroi M, Jeney A. Invasive growth and topoisomerase-switch induced by tumorous extracellular matrix in osteosarcoma cell culture Cell Biology International. 29: 959-967. PMID 16242975 DOI: 10.1016/J.Cellbi.2005.08.010 |
0.363 |
|
| 2005 |
Tímár J, Tóvári J, Rásó E, Mészáros L, Bereczky B, Lapis K. Platelet-mimicry of cancer cells: epiphenomenon with clinical significance. Oncology. 69: 185-201. PMID 16138000 DOI: 10.1159/000088069 |
0.779 |
|
| 2005 |
Bereczky B, Gilly R, Rásó E, Vágó A, Tímár J, Tóvári J. Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest. Clinical & Experimental Metastasis. 22: 69-76. PMID 16132580 DOI: 10.1007/S10585-005-3859-6 |
0.789 |
|
| 2005 |
Tóvári J, Gilly R, Rásó E, Paku S, Bereczky B, Varga N, Vágó A, Tímár J. Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models. Cancer Research. 65: 7186-93. PMID 16103069 DOI: 10.1158/0008-5472.Can-04-2498 |
0.805 |
|
| 2005 |
Timár J, Mészáros L, Orosz Z, Albini A, Rásó E. WT1 expression in angiogenic tumours of the skin Histopathology. 47: 67-73. PMID 15982325 DOI: 10.1111/J.1365-2559.2005.02169.X |
0.372 |
|
| 2005 |
Tímár J, Ladányi A, Forster-Horváth C, Lukits J, Döme B, Remenár E, Godény M, Kásler M, Bencsik B, Répássy G, Szabó G, Velich N, Suba Z, Elo J, Balatoni Z, et al. Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3421-32. PMID 15908653 DOI: 10.1200/Jco.2005.06.005 |
0.776 |
|
| 2005 |
Kopper L, Tímár J. Genomics of lung cancer may change diagnosis, prognosis and therapy. Pathology Oncology Research : Por. 11: 5-10. PMID 15800676 DOI: 10.1007/Bf03032399 |
0.421 |
|
| 2005 |
Tímár J, Csuka O, Remenár E, Répássy G, Kásler M. Progression of head and neck squamous cell cancer. Cancer Metastasis Reviews. 24: 107-27. PMID 15785876 DOI: 10.1007/S10555-005-5051-5 |
0.448 |
|
| 2005 |
Döme B, Rásó E, Dobos J, Mészáros L, Varga N, Puskás LG, Fehér LZ, Fehér LZ, Lörincz T, Ladányi A, Trikha M, Honn KV, Tímár J. Parallel expression of alphaIIbbeta3 and alphavbeta3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype. International Journal of Cancer. 116: 27-35. PMID 15761867 DOI: 10.1002/Ijc.20991 |
0.395 |
|
| 2004 |
Tóvári J, Bereczky B, Gilly R, Skopál J, Vágó A, Tímár J. [Heparin inhibits metastatization of experimental melanoma]. Magyar Onkologia. 48: 235-41. PMID 15520874 |
0.767 |
|
| 2004 |
Lôrincz T, Tímár J, Szendrôi M. Alterations of microvascular density in bone metastases of adenocarcinomas. Pathology Oncology Research : Por. 10: 149-53. PMID 15448750 DOI: 10.1007/Bf03033743 |
0.424 |
|
| 2004 |
Dobos J, Tímár J, Bocsi J, Burián Z, Nagy K, Barna G, Peták I, Ladányi A. In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. International Journal of Cancer. 112: 771-6. PMID 15386380 DOI: 10.1002/Ijc.20473 |
0.402 |
|
| 2004 |
Rásó E, Döme B, Somlai B, Zacharek A, Hagmann W, Honn KV, Tímár J. Molecular identification, localization and function of platelet-type 12-lipoxygenase in human melanoma progression, under experimental and clinical conditions. Melanoma Research. 14: 245-50. PMID 15305153 DOI: 10.1097/01.Cmr.0000138479.00897.D8 |
0.415 |
|
| 2004 |
Tímár J. [Report of the National Oncology Research and Developement Consortium, 2003]. Magyar Onkologia. 48: 75-9. PMID 15105900 |
0.324 |
|
| 2004 |
Tímár J. [Molecular mechanism of tumor progression. From Krompecher to the DNA microarray]. Magyar Onkologia. 48: 3-11. PMID 15105890 |
0.361 |
|
| 2004 |
Forster-Horváth C, Döme B, Paku S, Ladányi A, Somlai B, Jalkanen S, Tímár J. Loss of vascular adhesion protein-1 expression in intratumoral microvessels of human skin melanoma. Melanoma Research. 14: 135-40. PMID 15057044 DOI: 10.1097/00008390-200404000-00010 |
0.374 |
|
| 2004 |
Rásó E, Mészáros L, Albini A, Tímár J. A WT1 expressing metastatic human Kaposi sarcoma xenograft model. Pathology Oncology Research : Por. 10: 22-5. PMID 15029257 DOI: 10.1007/Bf02893404 |
0.4 |
|
| 2004 |
Tímár J, Udvarhelyi N, Bánfalvi T, Gilde K, Orosz Z. Accuracy of the determination of S100B protein expression in malignant melanoma using polyclonal or monoclonal antibodies Histopathology. 44: 180-184. PMID 14764062 DOI: 10.1111/J.1365-2559.2004.01800.X |
0.314 |
|
| 2004 |
Ladányi A, Somlai B, Gilde K, Fejös Z, Gaudi I, Tímár J. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 521-30. PMID 14760073 DOI: 10.1158/1078-0432.Ccr-1161-03 |
0.321 |
|
| 2004 |
Timar J, Gillyen R, Lovey J, Bereczky B, Tovari J. Effect of rH-erythropoietin-a on tumor vasculature and sensitivity to irradiation in epidermoid cancer xenograft. Journal of Clinical Oncology. 22: 5597-5597. DOI: 10.1200/Jco.2004.22.14_Suppl.5597 |
0.428 |
|
| 2004 |
Talor E, Timar J, Repassy G, Szabo G, Remenar E, Balatoni Z, Zemplen B. Leukocyte interleukin, injection (LI) treatment in advanced primary squamous cell carcinoma of the head & neck a phase II multi-center trial and pathology study Journal of Clinical Oncology. 22: 2605-2605. DOI: 10.1200/Jco.2004.22.14_Suppl.2605 |
0.384 |
|
| 2003 |
Tímár J, Forster-Horváth C, Lukits J, Döme B, Ladányi A, Remenár E, Kásler M, Bencsik M, Répássy G, Szabó G, Velich N, Suba Z, Elõ J, Balatoni Z, Bajtai A, et al. The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical Trial. The Laryngoscope. 113: 2206-17. PMID 14660929 DOI: 10.1097/00005537-200312000-00031 |
0.801 |
|
| 2003 |
Lövey J, Fazekas K, Ladányi A, Németh G, Tímár J. Low-dose irradiation and short-exposure suboptimal-dose paclitaxel adversely modulate metastatic potential of squamous carcinoma cells. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 179: 812-8. PMID 14652669 DOI: 10.1007/S00066-003-1051-Y |
0.393 |
|
| 2003 |
Paku S, Tóvári J, Lörincz Z, Timár F, Döme B, Kopper L, Raz A, Tímár J. Adhesion dynamics and cytoskeletal structure of gliding human fibrosarcoma cells: a hypothetical model of cell migration. Experimental Cell Research. 290: 246-53. PMID 14567984 DOI: 10.1016/S0014-4827(03)00334-3 |
0.338 |
|
| 2003 |
Döme B, Tímár J, Paku S. A novel concept of glomeruloid body formation in experimental cerebral metastases. Journal of Neuropathology and Experimental Neurology. 62: 655-61. PMID 12834110 DOI: 10.1093/Jnen/62.6.655 |
0.42 |
|
| 2003 |
Bánfalvi T, Udvarhelyi N, Orosz Z, Gergye M, Gilde K, Tímár J. Heterogenous S-100B protein expression patterns in malignant melanoma and association with serum protein levels. Oncology. 64: 374-379. PMID 12759535 DOI: 10.1159/000070296 |
0.337 |
|
| 2003 |
Tímár J, Ladányi A, Peták I, Jeney A, Kopper L. Molecular pathology of tumor metastasis III. Target array and combinatorial therapies. Pathology Oncology Research : Por. 9: 49-72. PMID 12704448 DOI: 10.1007/Bf03033715 |
0.404 |
|
| 2003 |
Tímár J. [Report on the first year of the activity of the National Oncological RD Consortium]. Magyar Onkologia. 46: 297-300. PMID 12563351 DOI: HUON.2002.46.4.0297 |
0.317 |
|
| 2003 |
Lapis K, Tímár J. Role of elastin-matrix interactions in tumor progression. Seminars in Cancer Biology. 12: 209-17. PMID 12083851 DOI: 10.1016/S1044-579X(02)00024-X |
0.351 |
|
| 2002 |
Tímár J, Csuka O, Orosz Z, Jeney A, Kopper L. Molecular pathology of tumor metastasis. II. Molecular staging and differential diagnosis. Pathology Oncology Research : Por. 8: 204-19. PMID 12516003 DOI: 10.1007/Bf03032397 |
0.408 |
|
| 2002 |
Trikha M, Timar J, Zacharek A, Nemeth JA, Cai Y, Dome B, Somlai B, Raso E, Ladanyi A, Honn KV. Role for beta3 integrins in human melanoma growth and survival. International Journal of Cancer. 101: 156-67. PMID 12209993 DOI: 10.1002/Ijc.10521 |
0.453 |
|
| 2002 |
Tímár J, Lapis K, Dudás J, Sebestyén A, Kopper L, Kovalszky I. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Seminars in Cancer Biology. 12: 173-86. PMID 12083848 DOI: 10.1016/S1044-579X(02)00021-4 |
0.316 |
|
| 2002 |
Tímár J, Rásó E, Döme B, Ladányi A, Bánfalvi T, Gilde K, Raz A. Expression and function of the AMF receptor by human melanoma in experimental and clinical systems Clinical & Experimental Metastasis. 19: 225-232. PMID 12067203 DOI: 10.1023/A:1015595708241 |
0.452 |
|
| 2002 |
Trikha M, Zhou Z, Timar J, Raso E, Kennel M, Emmell E, Nakada MT. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Research. 62: 2824-33. PMID 12019160 |
0.314 |
|
| 2002 |
Tímár J, Csuka O, Orosz Z, Jeney A, Kopper L. Molecular pathology of tumor metastasis. I. Predictive pathology. Pathology Oncology Research : Por. 7: 217-30. PMID 11692150 DOI: 10.1007/Bf03032353 |
0.432 |
|
| 2001 |
Ladányi A, Gallai M, Paku S, Nagy JO, Dudás J, Tímár J, Kovalszky I. Expression of a decorin-like moleculein human melanoma. Pathology Oncology Research : Por. 7: 260-6. PMID 11882905 DOI: 10.1007/Bf03032382 |
0.41 |
|
| 2001 |
Döme B, Somlai B, Ladányi A, Fazekas K, Zöller M, Tímár J. Expression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma Virchows Archiv. 439: 628-635. PMID 11764382 DOI: 10.1007/S004280100451 |
0.437 |
|
| 2001 |
Lukits J, Timár J, Juhász A, Döme B, Paku S, Répássy G. Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 125: 18-22. PMID 11458208 DOI: 10.1067/Mhn.2001.116187 |
0.798 |
|
| 2001 |
Forster-Horváth C, Bocsi J, Rásó E, Orbán TI, Olah E, Tímár J, Ladányi A. Constitutive intracellular expression and activation-induced cell surface up-regulation of CD44v3 in human T lymphocytes. European Journal of Immunology. 31: 600-8. PMID 11180125 DOI: 10.1002/1521-4141(200102)31:2<600::Aid-Immu600>3.0.Co;2-8 |
0.321 |
|
| 2001 |
Rásó E, Tóvári J, Tóth K, Paku S, Trikha M, Honn K, Tímár J. Ectopic αIIbβ3 Integrin Signaling Involves 12-Lipoxygenaseand PKC-mediated Serine Phosphorylation Events in Melanoma Cells Thrombosis and Haemostasis. 85: 1037-1042. DOI: 10.1055/S-0037-1615960 |
0.374 |
|
| 2001 |
Lovey J, Fazekas K, Ladanyi A, Németh G, Timar J. In vitro/in vivo effects of Taxol on the antitumoral action of irradiation in experimental human tumor model European Journal of Cancer. 37. DOI: 10.1016/S0959-8049(01)80970-9 |
0.358 |
|
| 2000 |
Lukits J, Döme B, Juhász A, Paku S, Tímár J, Répássy G. [Characterization of laryngopharyngeal tumors. Tumor size and vascularization] Magyar Onkologia. 44: 239-245. PMID 12050753 |
0.805 |
|
| 2000 |
Fazekas K, Csuka O, Köves I, Rásó E, Tímár J. Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis. Clinical & Experimental Metastasis. 18: 639-649. PMID 11827067 DOI: 10.1023/A:1013136303880 |
0.412 |
|
| 2000 |
Paku S, Döme B, Tóth R, Timár J. Organ-specificity of the extravasation process: an ultrastructural study. Clinical & Experimental Metastasis. 18: 481-492. PMID 11592305 DOI: 10.1023/A:1011858925376 |
0.428 |
|
| 2000 |
Haak-Frendscho M, Darvas Z, Hegyesi H, Kárpáti S, Hoffman RL, László V, Bencsáth M, Szalai C, Fürész J, Timár J, Bata-Csörgõ Z, Szabad G, Pivarcsi A, Pállinger E, Kemény L, et al. Histidine decarboxylase expression in human melanoma Journal of Investigative Dermatology. 115: 345-352. PMID 10951267 DOI: 10.1046/J.1523-1747.2000.00054.X |
0.36 |
|
| 2000 |
Tímár J, Tóth J. Tumor sinuses- vascular channels. Pathology & Oncology Research. 6: 83-86. PMID 10936781 DOI: 10.1007/Bf03032354 |
0.441 |
|
| 2000 |
Timár J, Rásó E, Döme B, Li L, Grignon D, Nie D, Honn KV, Hagmann W. Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. International Journal of Cancer. 87: 37-43. PMID 10861450 DOI: 10.1002/1097-0215(20000701)87:1<37::Aid-Ijc6>3.0.Co;2-L |
0.328 |
|
| 2000 |
Várkonyi J, Zalatnai A, Timár J, Matolcsi A, Falus A, Bencsáth M, László V, Pócsik E, Kotlán B, Császár A. Secondary cutaneous infiltration in B cell chronic lymphocytic leukemia. Acta Haematologica. 103: 116-21. PMID 10838457 DOI: 10.1159/000041031 |
0.308 |
|
| 2000 |
Timár J, Rásó E, Honn KV, Hagmann W. 12-lipoxygenase expression in human melanoma cell lines. Advances in Experimental Medicine and Biology. 469: 617-22. PMID 10667390 DOI: 10.1007/978-1-4615-4793-8_89 |
0.399 |
|
| 1999 |
Timar J, Trikha M, Szekeres K, Bazaz R, Honn K. Expression and function of the high affinity alphaIIbbeta3 integrin in murine melanoma cells. Clinical & Experimental Metastasis. 16: 437-45. PMID 10091939 DOI: 10.1023/A:1006533508560 |
0.419 |
|
| 1999 |
Timar J, Raso E, Paku S, Kopper L. Oral administration of a trace element preparation and zinc inhibit liver metastasis of 3LL-HH murine tumor cells. International Journal of Molecular Medicine. 2: 105-8. PMID 9854152 DOI: 10.3892/Ijmm.2.1.105 |
0.376 |
|
| 1999 |
Tang DG, Li L, Zhu Z, Joshi B, Johnson CR, Marnett LJ, Honn KV, Crissman JD, Krajewski S, Reed JC, Timar J, Porter AT. BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases. Pathology Oncology Research : Por. 4: 179-90. PMID 9761936 DOI: 10.1007/Bf02905247 |
0.304 |
|
| 1999 |
Timar J, Dome B, Raso E, Ladanyi A, Trikha M, Somlai B, Horvath A. Ectopic expression of allbb3 integrin in human melanoma modulate organ metastasis European Journal of Cancer. 35. DOI: 10.1016/S0959-8049(99)81922-4 |
0.321 |
|
| 1998 |
Ladányi A, Nagy JO, Jeney A, Tímár J. Cytokine sensitivity of metastatic human melanoma cell lines-- simultaneous inhibition of proliferation and enhancement of gelatinase activity. Pathology Oncology Research : Por. 4: 108-14. PMID 9654595 DOI: 10.1007/Bf02904703 |
0.331 |
|
| 1998 |
Paku S, Bodoky G, Kupcsulik P, Tímár J. Blood Supply of Metastatic Hepatic Tumors: Suggestions for Improved Delivery of Chemotherapeutic Agents Journal of the National Cancer Institute. 90: 936-937. PMID 9637145 DOI: 10.1093/Jnci/90.12.936 |
0.337 |
|
| 1998 |
Trikha M, Raso E, Cai Y, Fazakas Z, Paku S, Porter AT, Timar J, Honn KV. Role of alphaII(b)beta3 integrin in prostate cancer metastasis. The Prostate. 35: 185-92. PMID 9582087 DOI: 10.1002/(Sici)1097-0045(19980515)35:3<185::Aid-Pros4>3.0.Co;2-G |
0.324 |
|
| 1998 |
Répássy G, Forster-Horváth C, Juhász A, Adány R, Tamássy A, Tímár J. Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathology Oncology Research : Por. 4: 14-21. PMID 9555115 DOI: 10.1007/Bf02904689 |
0.376 |
|
| 1997 |
Tímár J, Tóvári J, Szekeres K, Kagawa D, Honn KV. Key determinants of the invasion mechanism of melanoma. Role for a new signaling pathway. Advances in Experimental Medicine and Biology. 407: 303-10. PMID 9321968 DOI: 10.1007/978-1-4899-1813-0_45 |
0.432 |
|
| 1997 |
Chen YQ, Trikha M, Gao X, Bazaz R, Porter AT, Timar J, Honn KV. Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological origin. International Journal of Cancer. 72: 642-8. PMID 9259405 DOI: 10.1002/(Sici)1097-0215(19970807)72:4<642::Aid-Ijc16>3.0.Co;2-D |
0.403 |
|
| 1997 |
Tóvári J, Paku S, Rásó E, Pogány G, Kovalszky I, Ladányi A, Lapis K, Tímár J. Role of sinusoidal heparan sulfate proteoglycan in liver metastasis formation. International Journal of Cancer. 71: 825-31. PMID 9180152 DOI: 10.1002/(Sici)1097-0215(19970529)71:5<825::Aid-Ijc21>3.0.Co;2-5 |
0.347 |
|
| 1996 |
KŐhalmi F, Strausz J, EgervÁry M, Szekeres G, TímáR J. Differential Expression of Markers in Extensive and Restricted Langerhans Cell Histiocytosis (LCH). Pathology & Oncology Research. 2: 184-187. PMID 11173605 DOI: 10.1007/Bf02903525 |
0.337 |
|
| 1996 |
Tímár J, Tóvári J, Pogány G, Ladányi A, Paku S, Rśó E, Bocsi J, Jeney A, Lapis K. The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells. European Journal of Cancer (Oxford, England : 1990). 152-9. PMID 8695225 DOI: 10.1016/0959-8049(95)00544-7 |
0.381 |
|
| 1995 |
Timár J, Jeney A, Kovalszky, Kopper L. Role of Proteoglycans in Tumor Progression. Pathology Oncology Research : Por. 1: 85-93. PMID 11173574 DOI: 10.1007/Bf02893590 |
0.446 |
|
| 1995 |
Ladányi A, Tímár J, Bocsi J, Tóvári J, Lapis K. Sex-dependent liver metastasis of human melanoma lines in scid mice Melanoma Research. 5: 83-86. PMID 7620343 DOI: 10.1097/00008390-199504000-00002 |
0.317 |
|
| 1995 |
Tímár J, Diczházi C, Bartha I, Pogány G, Paku S, Rásó E, Tóvári J, Ladányi A, Lapis K, Kopper L. Modulation of heparan-sulphate/chondroitin-sulphate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells. International Journal of Cancer. 62: 755-61. PMID 7558426 DOI: 10.1002/Ijc.2910620618 |
0.38 |
|
| 1994 |
Honn KV, Tang DG, Gao X, Butovich IA, Liu B, Timar J, Hagmann W. 12-Lipoxygenases and 12(S)-HETE: role in cancer metastasis Cancer and Metastasis Reviews. 13: 365-396. PMID 7712597 DOI: 10.1007/Bf00666105 |
0.358 |
|
| 1992 |
Raso E, Timar J, Lapis K. Development and characterization of a sex-dependent metastatic preputial gland adenocarcinoma in human tumor-bearing immunosuppressed F344 rats Carcinogenesis. 13: 1281-1284. PMID 1638699 DOI: 10.1093/Carcin/13.7.1281 |
0.38 |
|
| 1992 |
Liu B, Renaud C, Nelson KK, Chen YQ, Bazaz R, Kowynia J, Timar J, Diglio CA, Honn KV. Protein-kinase-C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization International Journal of Cancer. 52: 147-152. PMID 1379995 DOI: 10.1002/Ijc.2910520126 |
0.386 |
|
| 1992 |
Honn KV, Chen YQ, Timar J, Onoda JM, Hatfield JS, Fligiel SEG, Steinert BW, Diglio CA, Grossi IM, Nelson KK, Taylor JD. αIIbβ3 Integrin expression and function in subpopulations of murine tumors Experimental Cell Research. 201: 23-32. PMID 1377132 DOI: 10.1016/0014-4827(92)90344-8 |
0.354 |
|
| 1991 |
Timár J, Pogány G, Balázs M, Szöllösi J, Ladányi A, Oláh J, Timár F, Lapis K, Jeney A. Modulation of membrane phenotype, matrix adhesion and microinvasiveness of metastatic tumour cells by HUdR. Cell Biochemistry and Function. 8: 211-20. PMID 2272119 DOI: 10.1002/Cbf.290080405 |
0.346 |
|
| 1991 |
Szende B, Srkalovic G, Timar J, Mulchahey JJ, Neill JD, Lapis K, Csikos A, Szepeshazi K, Schally AV. Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 88: 4153-6. PMID 1851995 DOI: 10.1073/Pnas.88.10.4153 |
0.386 |
|
| 1991 |
Timar J, Lapis K, Fulop T, Varga ZS, Tixier JM, Robert L, Hornebeck W. Interaction between elastin and tumor cell lines with different metastatic potential; in vitro and in vivo studies. Journal of Cancer Research and Clinical Oncology. 117: 232-238. PMID 1851764 DOI: 10.1007/Bf01625430 |
0.404 |
|
| 1990 |
Timár J, Kovalszky I, Paku S, Lapis K, Kopper L. Two human melanoma xenografts with different metastatic capacity and glycosaminoglycan pattern. Journal of Cancer Research and Clinical Oncology. 115: 554-7. PMID 2606930 DOI: 10.1007/Bf00391357 |
0.405 |
|
| 1990 |
Tímár J, Ladányi A, Lapis K, Moczar E. Galactosylated glycan expression and macrophage sensitivity of Lewis lung tumor cells with different metastatic phenotype. Journal of Cancer Research and Clinical Oncology. 116: 264-270. PMID 2370252 DOI: 10.1007/Bf01612901 |
0.44 |
|
| 1990 |
Paku S, Timár J, Lapis K. Ultrastructure of invasion in different tissue types by lewis lung tumour variants Virchows Archiv. 417: 435-442. PMID 2122587 DOI: 10.1007/Bf01606032 |
0.34 |
|
| 1990 |
Caux F, Timar J, Moczar E, Lapis K, Moczar M. Cell-associated glycosaminoglycans in human melanoma cell culture. Biochemical Society Transactions. 18: 294-295. PMID 2116337 DOI: 10.1042/Bst0180294 |
0.32 |
|
| 1990 |
Timár J, Kovalszky I, Bánkfalvi A, Kopper L. Ultrastructural localization and internalization of proteoglycan epitopes in a human non-Hodgkin (B) lymphoma. Histochemistry. 94: 419-25. PMID 1699917 DOI: 10.1007/Bf00266450 |
0.307 |
|
| 1989 |
Pogány G, Moczar E, Jeney A, Timár J, Timár F, Ditrói K, Lapis K. Comparative study on Lewis lung tumour lines with 'low' and 'high' metastatic capacity. III. Glycosaminoglycan synthesis, transport and degradation in cell lines. Clinical & Experimental Metastasis. 7: 659-669. PMID 2776370 DOI: 10.1007/Bf01753676 |
0.302 |
|
| 1987 |
Timár J, Móczar E, Timár F, Pál K, Kopper L, Lapis K, Jeney A. Comparative study on Lewis lung tumor lines with 'low' and 'high' metastatic capacity. II. Cytochemical and biochemical evidence for differences in glycosaminoglycans. Clinical & Experimental Metastasis. 5: 79-87. PMID 3103961 DOI: 10.1007/Bf00116628 |
0.383 |
|
| 1983 |
Timár J, Kopper L, Pál K, Lapis K. Transmission and scanning-electronmicroscopy of experimental liver metastases derived from intrasplenically growing primary tumor. Pathology, Research and Practice. 177: 47-59. PMID 6622294 DOI: 10.1016/S0344-0338(83)80043-0 |
0.334 |
|
| Show low-probability matches. |